abiraterone-prednisone
Selected indexed studies
- Abiraterone in metastatic prostate cancer without previous chemotherapy. (N Engl J Med, 2013) [PMID:23228172]
- Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study. (Ann Oncol, 2026) [PMID:41120017]
- Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial. (Eur J Cancer, 2025) [PMID:41045691]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study. (2026) pubmed
- Abiraterone in metastatic prostate cancer without previous chemotherapy. (2013) pubmed
- Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial. (2025) pubmed
- Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway). (2024) pubmed
- Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone. (2019) pubmed
- Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study. (2021) pubmed
- Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial. (2014) pubmed
- Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents. (2023) pubmed
- An expanded metabolic pathway for androgen production by commensal bacteria. (2025) pubmed
- Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States. (2020) pubmed